BioKDE: Biomedical Knowledge Discovery Engine

Contact Us Login
Sorted by:  
Results by Year
Article Type
Publication date
  1,930,870 results (0.071 seconds)
1
Breast cancer.
Nadia Harbeck, Frédérique Penault-Llorca, +6 authors, Fatima Cardoso.
Nat Rev Dis Primers, 2019 Sep 25; 5(1). PMID: 31548545
Highly Cited. Review.
2
Immunotherapy and targeted therapy combinations in metastatic breast cancer.
Francisco J Esteva,  Vanessa M Hubbard-Lucey,  Jun Tang,  Lajos Pusztai.
Lancet Oncol, 2019 Mar 08; 20(3). PMID: 30842061
Highly Cited. Review.
3
Clinical utility of gene-expression signatures in early stage breast cancer.
Maryann Kwa,  Andreas Makris,  Francisco J Esteva.
Nat Rev Clin Oncol, 2017 Jun 01; 14(10). PMID: 28561071
Highly Cited. Review.
4
Breast Cancer in Men.
Sharon H Giordano.
N Engl J Med, 2018 Jun 14; 378(24). PMID: 29897847
Highly Cited. Review.
5
Inflammatory breast cancer biology: the tumour microenvironment is key.
Bora Lim, Wendy A Woodward, +2 authors, Naoto T Ueno.
Nat Rev Cancer, 2018 Apr 29; 18(8). PMID: 29703913
Highly Cited. Review.
6
Breast cancer.
Nadia Harbeck,  Michael Gnant.
Lancet, 2016 Nov 21; 389(10074). PMID: 27865536
Highly Cited. Review.
7
Advances in the treatment of advanced oestrogen-receptor-positive breast cancer.
Nicholas C Turner,  Patrick Neven,  Sibylle Loibl,  Fabrice Andre.
Lancet, 2016 Dec 13; 389(10087). PMID: 27939057
Highly Cited. Review.
8
Molecular alterations in triple-negative breast cancer-the road to new treatment strategies.
Carsten Denkert,  Cornelia Liedtke,  Andrew Tutt,  Gunter von Minckwitz.
Lancet, 2016 Dec 13; 389(10087). PMID: 27939063
Highly Cited. Review.
9
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
Lancet Oncol, 2017 Dec 16; 19(1). PMID: 29242041     Free PMC article
Highly Cited. Review.
10
Triple-negative breast cancer in African-American women: disparities versus biology.
Eric C Dietze, Christopher Sistrunk, +2 authors, Victoria L Seewaldt.
Nat Rev Cancer, 2015 Feb 13; 15(4). PMID: 25673085     Free PMC article
Highly Cited. Review.
11
Targeting the PI3-kinase pathway in triple-negative breast cancer.
J Pascual,  N C Turner.
Ann Oncol, 2019 May 06; 30(7). PMID: 31050709
Highly Cited. Review.
12
HER2-positive breast cancer.
Sibylle Loibl,  Luca Gianni.
Lancet, 2016 Dec 13; 389(10087). PMID: 27939064
Highly Cited. Review.
13
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.
Giampaolo Bianchini, Justin M Balko, +2 authors, Luca Gianni.
Nat Rev Clin Oncol, 2016 Oct 19; 13(11). PMID: 27184417     Free PMC article
Highly Cited. Review.
14
Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry.
Abenaa M Brewster,  Mariana Chavez-MacGregor,  Powel Brown.
Lancet Oncol, 2014 Dec 03; 15(13). PMID: 25456381     Free PMC article
Highly Cited. Review.
15
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Patricia Cortazar, Lijun Zhang, +34 authors, Gunter von Minckwitz.
Lancet, 2014 Feb 18; 384(9938). PMID: 24529560
Highly Cited. Review.
16
The immune system and response to HER2-targeted treatment in breast cancer.
Giampaolo Bianchini,  Luca Gianni.
Lancet Oncol, 2014 Feb 01; 15(2). PMID: 24480556
Highly Cited. Review.
17
Precision medicine for metastatic breast cancer--limitations and solutions.
Monica Arnedos, Cecile Vicier, +4 authors, Fabrice Andre.
Nat Rev Clin Oncol, 2015 Jul 22; 12(12). PMID: 26196250
Highly Cited. Review.
18
Clinical management of breast cancer heterogeneity.
Dimitrios Zardavas,  Alexandre Irrthum,  Charles Swanton,  Martine Piccart.
Nat Rev Clin Oncol, 2015 Apr 22; 12(7). PMID: 25895611
Highly Cited. Review.
19
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment.
Ana C Garrido-Castro,  Nancy U Lin,  Kornelia Polyak.
Cancer Discov, 2019 Jan 27; 9(2). PMID: 30679171     Free PMC article
Highly Cited. Review.
20
Natural and therapy-induced immunosurveillance in breast cancer.
Guido Kroemer, Laura Senovilla, +2 authors, Laurence Zitvogel.
Nat Med, 2015 Oct 09; 21(10). PMID: 26444637
Highly Cited. Review.
1 2 3 4 5 6 7 8 9 10 Next